22147 - Ph2/3 CTX-009 + Paclitaxel vs. Paclitaxel in mBiliary Tract

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

Disease Types: Cholangiocarcinoma,  Gall Bladder,  Other,&nbs

Available at: {clinical_trial_location backspace="7"}22147 - Ph2/3 CTX-009 + Paclitaxel vs. Paclitaxel in mBiliary Tract, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}